These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9796065)

  • 1. Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use.
    Deliyannis G; Jackson DC; Dyer W; Bates J; Coulter A; Harling-McNabb L; Brown LE
    Vaccine; 1998 Dec; 16(20):2058-68. PubMed ID: 9796065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines.
    Coulter A; Wong TY; Drane D; Bates J; Macfarlan R; Cox J
    Vaccine; 1998 Jul; 16(11-12):1243-53. PubMed ID: 9682385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
    Gasper DJ; Neldner B; Plisch EH; Rustom H; Carrow E; Imai H; Kawaoka Y; Suresh M
    PLoS Pathog; 2016 Dec; 12(12):e1006064. PubMed ID: 27997610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.
    Rimmelzwaan GF; Nieuwkoop N; Brandenburg A; Sutter G; Beyer WE; Maher D; Bates J; Osterhaus AD
    Vaccine; 2000 Dec; 19(9-10):1180-7. PubMed ID: 11137255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.
    Coulter A; Harris R; Davis R; Drane D; Cox J; Ryan D; Sutton P; Rockman S; Pearse M
    Vaccine; 2003 Feb; 21(9-10):946-9. PubMed ID: 12547607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS).
    Ennis FA; Cruz J; Jameson J; Klein M; Burt D; Thipphawong J
    Virology; 1999 Jul; 259(2):256-61. PubMed ID: 10388649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
    Sjölander A; Lövgren Bengtsson K; Johansson M; Morein B
    Scand J Immunol; 1996 Feb; 43(2):164-72. PubMed ID: 8633196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
    Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
    Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses.
    Sjölander S; Drane D; Davis R; Beezum L; Pearse M; Cox J
    Vaccine; 2001 Jul; 19(28-29):4072-80. PubMed ID: 11427284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
    Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
    Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of priming on subsequent response to inactivated influenza vaccine.
    Potter CW; Jennings R
    Vaccine; 2003 Feb; 21(9-10):940-5. PubMed ID: 12547606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs.
    Ghazi HO; Potter CW; Smith TL; Jennings R
    J Med Microbiol; 1995 Jan; 42(1):53-61. PubMed ID: 7739026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
    Paillot R; Prowse L
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice.
    Katz JM; Lu X; Todd CW; Newman MJ
    Vaccine; 2000 Apr; 18(21):2177-87. PubMed ID: 10717336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of lung CD8
    Moriyama M; Takeyama H; Hasegawa H; Ichinohe T
    Vaccine; 2017 Dec; 35(48 Pt B):6620-6626. PubMed ID: 29079103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.